1-3 of 3
Christina Bamia
Close
Sort by
Journal Articles

DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7

Maria Gkotzamanidou, Evangelos Terpos, Christina Bamia, Nikhil C. Munshi, Meletios A. Dimopoulos, Vassilis L. Souliotis
Journal: Blood
Blood (2016) 128 (9): 1214–1225.
https://doi.org/10.1182/blood-2016-01-691618
Published: 2016
Includes: Supplemental data
Journal Articles

Decreased Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma (MM) Treated with Zoledronic Acid (ZA) after Application of Preventive Measures.

Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis, MD, Christina Bamia, Ioannis Melakopoulos, MD, Dimitra Gika, Maria Roussou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Aristotle Bamias, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3609.
https://doi.org/10.1182/blood.V110.11.3609.3609
Published: 2007
Journal Articles

Melphalan-Induced DNA Damage In Vitro as Predictor for Clinical Outcome in Multiple Myeloma.

Meletios A. Dimopoulos, MD, Vassilis L. Souliotis, PhD, Athanasios Anagnostopoulos, M.D., Christina Bamia, PhD, Anastasia Pouli, M.D., Ioannis Baltadakis, M.D., Evangelos Terpos, M.D., Soterios A. Kyrtopoulos, PhD, Petros P. Sfikakis, M.D.
Journal: Blood
Blood (2006) 108 (11): 60.
https://doi.org/10.1182/blood.V108.11.60.60
Published: 2006